Billy Joel has been performing his hit songs all over the world for decades, but a recent concert in Connecticut didn't go as ...

Obesity is a major risk factor for joint failure because excess weight puts more stress on the implants, leading to ...

Shares of WW International (NASDAQ:WW) have reversed Thursday’s after-hours gains as guarded remarks from the company’s CEO ...

Ozempic and its ilk may do a lot of things, but raising the risk of suicide doesn’t appear to be one of them. Research out ...

Yes, the same company known for DNA testing and ancestry records is now helping connect people to GLP-1 prescriptions and other medications via Lemonaid Health, its telehealth platform designed to ...

Hims & Hers reported its Q4 earnings this week. The company is growing quickly but faces a potential legal threat to its ...

Madrigal Pharmaceuticals' Rezdiffra had a strong launch with $103.3M in Q4 sales and solid liquidity. See why I have a ...

Eli Lilly is seeking to further cement its stance as a leader in weight loss drugs in an ad campaign calling out “unapproved” medications.

India's largest drugmaker by revenue Sun Pharmaceutical is aiming to launch its experimental anti-obesity and type 2 diabetes ...

Jab for joy? A landmark study of nearly 30,000 patients found that the use of GLP-1 medications, which include Wegovy and Ozempic, could have “an antidepressant effect,” suggesting ...

Health insurance companies are lobbying against proposals that would expand prescription access to weight-loss medications.

Once again, Eli Lilly is using Hollywood’s biggest night as a platform to speak out on a hot-button issue in pharma. | Once ...